Chemogenomic approaches to rational drug design

Area of Science:

• Computational chemistry
• Genomics
• Pharmacology

Background:

• Drug design paradigms are shifting towards systems biology approaches.
• Genomic sequencing and high-throughput screening enable large-scale compound and target evaluation.
• Chemogenomics studies the biological effects of small molecules on multiple targets.

Purpose of the Study:

• To review predictive in silico chemogenomic approaches.
• To foster rational drug design by analyzing complex biological data.
• To derive insights from simultaneous multi-compound, multi-target evaluations.

Main Methods:

• Focus on predictive in silico chemogenomic methodologies.
• Utilizing information technologies for data analysis and prediction.
• Presenting state-of-the-art methods for ligand and target space navigation.

Main Results:

• Information technologies are crucial for managing large chemogenomic datasets.
• In silico approaches facilitate the analysis of multi-compound, multi-target interactions.
• Review covers methods for navigating ligand and target spaces.

Conclusions:

• In silico chemogenomics offers a powerful approach for rational drug design.
• Systematic analysis of large datasets is key to discovering novel therapeutics.
• The field enables a shift from single-target to systems-level drug discovery.